Administration of the antibacterial agents flumequine and oxolinic acid to small turbot (Scophthalmus maximus L.) by bath

Journal of Applied Ichthyology

Volumn 19, Issue 1, 2003, Pages 55-58

  Samuelsen, O B ^a  

^a Armauer Hansens Hus ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL ACTIVITY;

SCOPHTHALMUS; SCOPHTHALMUS MAXIMUS; VISCUM; VISCUM ALBUM;

EID: 0037293625     PISSN: 01758659     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0426.2003.00352.x     Document Type: Article

References (31)

1. Austin, B.; Rayment, J.; Alderman, D.J., 1983: Control of furunculosis by oxolinic acid. Aquaculture 31, 101-108.
2. Barnes, A.C.; Lewin, C.S.; Hastings, T.S., 1990: In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida. Antimicrob. Agents Chemother. 34, 1819-1820.
3. Blaser, J.; Stone, B.B.; Groner, M.C.; Zinner, S.H., 1987: Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob. Agents Chemother. 31, 1054-1060.
4. Chevalier, R.; Gerard, J.P.; Michel, C., 1981: Distribution et cinétique tissulaire de la flumequine chez la truite arc-en-ciel (Salmo gairdneri, Richardson). Rev. Méd. Vét. 132, 831-837.
5. th international conference of the EAFP. Dublin. 9-14 September P-181.
6. Dhert, P.; Lavens, P.; Dehasque, M.; Sorgeloos, P., 1994: Improvements in the larviculture of turbot Scophthalmus maximus: zootechnical and nutritional aspects, possibility for disease control. In: Turbot culture: problems and prospects. P. Lavens, R.A.M. Remmerswaal, (eds), Gent, Belgium, pp. 32-46.
7. Elema, M.O.; Hoff, K.A.; Kristensen, H.G., 1994: Multiple-dose pharmacokinetic study of flumequine in Atlantic salmon (Salmo salar L.). Aquaculture 128, 1-11.
8. Hansen, M.K.; Horsberg, T.E., 1999: Single-dose pharmacokinetics of flumequine in halibut (Hippoglossus hippoglossus) and turbot (Scophthalmus maximus). J. Vet. Pharmacol. Therapeut. 22, 122-126.
9. Hansen, M.K.; Horsberg, T.E., 2000 : Single-dose pharmacokinetics of flumequine in cod (Gadus morhua) and goldsinny wrasse (Ctenolabrus rupestris). J. Vet. Pharmacol. Therapeut. 23, 163-168.
10. Hiney, M.P.; Coyne, R.; Kerry, J.; Pursell, L.; Samuelsen, O.B.; Smith, P., 1995: Failure of Flumisol bath treatments during commercial transport of salmon smolts to prevent the activation of stress inducible furunculosis. Aquaculture 136, 31-42.
11. Hiney, M.; Samuelsen, O.B.; Smith, P., 1994: Association of mortalities in a salmon hatchery with the oral administration of flumequine. Bull. Eur. Assoc. Fish Pathol. 14, 204-206.
12. Lunestad, B.T.; Samuelsen, O.B.; Fjelde, S.; Ervik, A., 1995: Photostability of eight antibacterials in seawater. Aquaculture 134, 217-225.
13. Martinsen, B., 1993: Quinolones as antimicrobial drugs in aquaculture: Antimicrobial activities and pharmacokinetic properties. Dr. scient. thesis, Norwegian College of Veterinary Medicine. As, Norway.
14. Martinsen, B.; Horsberg, T.E., 1995: Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin and enrofloxacin in Atlantic salmon (Salmo salar) held in seawater at 10°C. Antimicrob. Agents Chemother. 39, 1059-1064.
15. Martinsen, B.; Oppegaaard, H.; Wichstrøm, R., Myhr, E., 1992: Temperature-dependent in vitro antimicrobial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fish. Antimicrob. Agents Chemother. 36, 1738-1743.
16. Michel, C.; Gerard, J.-P.; Fourbet, B.; Collas, R.; Chevalier, R., 1980: Emploi de la flumequine contre la furunculose des salmonides: Essais therapeutiques et perspectives pratiques. Bull. Française Piscicult. 277, 154-162.
17. O'Grady, P.; Moloney, M.; Smith, P.R., 1988: Bath administration of the quinolone antibiotic flumequine to brown trout (Salmo trutta) and Atlantic salmon (Salmon salar). Dis. Aquat. Org. 4, 27-33.
18. Poher, I.; Blanc, G., 1998: Pharmacokinetics of a discontinuous absorption process of oxolinic acid in turbot, Scophthalmus maximus, after a single oral administration. Xenobiotica 28, 1061-1073.
19. Pursell, L.; Samuelsen, O.B.; Smith, P., 1995: Reduction in the in vitro activity of flumequine against Aeromonas salmonicida in the presence of the concentrations of Mg and Ca ions found in sea water. Aquaculture 135, 245-255.
20. Rodgers, C.J.; Austin, B., 1983: Oxolinic acid for control of enteric redmouth disease in rainbow trout. Vet. Rec. 112, 83.
21. Rogstad, A.; Ellingsen, O.F.; Syvertsen, F., 1993: Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture 110, 207-220.
22. Samuelsen, O.B., 1997: Efficacy of bath-administered flumequine and oxolinic acid in the treatment of vibriosis in small Atlantic halibut. J. Aquat. Anim. Health 9, 127-131.
23. Samuelsen, O.B.; Ervik, A., 1997: Single dose pharmacokinetic study of flumequine after intravenous, intraperitoneal and oral administration to Atlantic halibut (Hippoglossus hippoglossus) held in seawater at 9°C. Aquaculture 158, 215-227.
24. Samuelsen, O.B.; Ervik, A., 2001: Absorption, tissue distribution and excretion of flumequine and oxolinic acid in corkwing wrasse (Symphodus melops) following administration by a single intraperitoneal injection or by bath. J. Vet. Pharmacol. Therapeut. 24, 111-116.
25. Samuelsen, O.B.; Lunestad, B.T., 1996: Bath treatment, an alternative method for the administration of the quinolones flumequine and oxolinic acid to halibut Hippoglossus hippoglossus and in vitro antibacterial activity of the drugs against some Vibrio sp. Dis. Aquat. Org. 27, 13-18.
26. Samuelsen, O.B.; Torkildsen, L.; Husgard, S.; Bergh, Ø., 2000a: The efficacy of a single intraperitoneal injection of flumequine in the treatment of systemic vibriosis in corkwing wrasse (Symphodus melops). J. Aquat. Anim. Health 12, 324-328.
27. Samuelsen, O.B.; Ervik, A.; Pursell, L.; Smith, P., 2000b: Single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic salmon (Salmo salar) held in seawater and in vitro antibacterial activity against Aeromonas salmonicida. Aquaculture 187, 213-224.
28. Scallan, A.; Smith, P.R., 1985: Control of asymptomatic carriage of Aeromonas salmonicida in Atlantic salmon smolts with flumequine, In: Fish and Shellfish Pathology. A.E. Ellis (ed), Academic Press, London, UK, pp. 119-127.
29. Soltani, M.; Shanker, S.; Munday, B.L., 1995: Chemotheraphy of Cytophaga Flexibacter-like bacteria (CFLB) infections in fish: studies validating clinical efficacies of selected antimicrobials. J. Fish Dis. 18, 555-565.
30. Stamm, J.M., 1989: In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and sarafloxacin (A-56620). J. Aquat. Anim. Health 1, 135-141.
31. Tsoumas, A.; Alderman, D.J.; Rogers, C.J., 1989: Aeromonas salmonicida: development of resistance to 4-quinolone antibacterials. J. Fish Dis. 12, 493-507.